431 related articles for article (PubMed ID: 28712806)
1. Structures of Human A
Cheng RKY; Segala E; Robertson N; Deflorian F; Doré AS; Errey JC; Fiez-Vandal C; Marshall FH; Cooke RM
Structure; 2017 Aug; 25(8):1275-1285.e4. PubMed ID: 28712806
[TBL] [Abstract][Full Text] [Related]
2. Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure.
Quarta D; Ferré S; Solinas M; You ZB; Hockemeyer J; Popoli P; Goldberg SR
J Neurochem; 2004 Mar; 88(5):1151-8. PubMed ID: 15009670
[TBL] [Abstract][Full Text] [Related]
3. Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride.
Giunta S; Andriolo V; Castorina A
Int J Biochem Cell Biol; 2014 Sep; 54():122-36. PubMed ID: 25058312
[TBL] [Abstract][Full Text] [Related]
4. Structure-based virtual screening discovers potent and selective adenosine A
Matricon P; Nguyen AT; Vo DD; Baltos JA; Jaiteh M; Luttens A; Kampen S; Christopoulos A; Kihlberg J; May LT; Carlsson J
Eur J Med Chem; 2023 Sep; 257():115419. PubMed ID: 37301076
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 1,3-diethyl-7-methyl-8-(phenoxymethyl)-xanthine derivatives as novel adenosine A
Harmse R; van der Walt MM; Petzer JP; Terre'Blanche G
Bioorg Med Chem Lett; 2016 Dec; 26(24):5951-5955. PubMed ID: 27836398
[TBL] [Abstract][Full Text] [Related]
6. The antidepressant-like effect of guanosine involves the modulation of adenosine A
Camargo A; Bettio LEB; Rosa PB; Rosa JM; Altê GA; Rodrigues ALS
Purinergic Signal; 2023 Jun; 19(2):387-399. PubMed ID: 36166131
[TBL] [Abstract][Full Text] [Related]
7. Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain.
Ferre S; Ciruela F; Borycz J; Solinas M; Quarta D; Antoniou K; Quiroz C; Justinova Z; Lluis C; Franco R; Goldberg SR
Front Biosci; 2008 Jan; 13():2391-9. PubMed ID: 17981720
[TBL] [Abstract][Full Text] [Related]
8. Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine.
Doré AS; Robertson N; Errey JC; Ng I; Hollenstein K; Tehan B; Hurrell E; Bennett K; Congreve M; Magnani F; Tate CG; Weir M; Marshall FH
Structure; 2011 Sep; 19(9):1283-93. PubMed ID: 21885291
[TBL] [Abstract][Full Text] [Related]
9. Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats.
Justinova Z; Ferre S; Segal PN; Antoniou K; Solinas M; Pappas LA; Highkin JL; Hockemeyer J; Munzar P; Goldberg SR
J Pharmacol Exp Ther; 2003 Dec; 307(3):977-86. PubMed ID: 14557381
[TBL] [Abstract][Full Text] [Related]
10. The adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion: a study in mice lacking adenosine A1 and/or A2A receptors.
Halldner L; Adén U; Dahlberg V; Johansson B; Ledent C; Fredholm BB
Neuropharmacology; 2004 Jun; 46(7):1008-17. PubMed ID: 15081797
[TBL] [Abstract][Full Text] [Related]
11. Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.
Schindler CW; Karcz-Kubicha M; Thorndike EB; Müller CE; Tella SR; Ferré S; Goldberg SR
Br J Pharmacol; 2005 Mar; 144(5):642-50. PubMed ID: 15678095
[TBL] [Abstract][Full Text] [Related]
12. Improvement of postural adjustment steps in hemiparkinsonian rats chronically treated with caffeine is mediated by concurrent blockade of A1 and A2A adenosine receptors.
Bata-García JL; Tun-Cobá L; Alvarez-Cervera FJ; Villanueva-Toledo JR; Heredia-López FJ; Góngora-Alfaro JL
Neuroscience; 2010 Mar; 166(2):590-603. PubMed ID: 20056138
[TBL] [Abstract][Full Text] [Related]
13. Caffeine exposure alters adenosine system and neurochemical markers during retinal development.
Brito R; Pereira-Figueiredo D; Socodato R; Paes-de-Carvalho R; Calaza KC
J Neurochem; 2016 Aug; 138(4):557-70. PubMed ID: 27221759
[TBL] [Abstract][Full Text] [Related]
14. Adenosine A
Jacobson KA; Gao ZG; Matricon P; Eddy MT; Carlsson J
Br J Pharmacol; 2022 Jul; 179(14):3496-3511. PubMed ID: 32424811
[TBL] [Abstract][Full Text] [Related]
15. Structure of the Adenosine A
Glukhova A; Thal DM; Nguyen AT; Vecchio EA; Jörg M; Scammells PJ; May LT; Sexton PM; Christopoulos A
Cell; 2017 Feb; 168(5):867-877.e13. PubMed ID: 28235198
[TBL] [Abstract][Full Text] [Related]
16. Comparative Study of Receptor-, Receptor State-, and Membrane-Dependent Cholesterol Binding Sites in A
Tzortzini E; Corey RA; Kolocouris A
J Chem Inf Model; 2023 Feb; 63(3):928-949. PubMed ID: 36637988
[TBL] [Abstract][Full Text] [Related]
17. An adenosine A1R-A2aR imbalance regulates low glucose/hypoxia-induced microglial activation, thereby contributing to oligodendrocyte damage through NF-κB and CREB phosphorylation.
Huang W; Bai S; Zuo X; Tang W; Chen P; Chen X; Wang G; Wang H; Xie P
Int J Mol Med; 2018 Jun; 41(6):3559-3569. PubMed ID: 29512780
[TBL] [Abstract][Full Text] [Related]
18. The allosteric enhancer PD81,723 increases chimaeric A1/A2A adenosine receptor coupling with Gs.
Bhattacharya S; Youkey RL; Ghartey K; Leonard M; Linden J; Tucker AL
Biochem J; 2006 May; 396(1):139-46. PubMed ID: 16390330
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A
Babich V; Vadnagara K; Di Sole F
J Cell Physiol; 2019 Aug; 234(8):13917-13930. PubMed ID: 30633335
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and preliminary evaluation of new 1- and 3-[1-(2-hydroxy-3-phenoxypropyl)]xanthines from 2-amino-2-oxazolines as potential A1 and A2A adenosine receptor antagonists.
Massip S; Guillon J; Bertarelli D; Bosc JJ; Léger JM; Lacher S; Bontemps C; Dupont T; Müller CE; Jarry C
Bioorg Med Chem; 2006 Apr; 14(8):2697-719. PubMed ID: 16386423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
